|By Marketwired .||
|April 7, 2014 02:01 AM EDT||
MANCHESTER, UNITED KINGDOM -- (Marketwired) -- 04/07/14 -- Epistem Holdings Plc (LSE: EHP), Manchester, UK, the biotechnology and personalized medicine company, today announced the successful installation of the Bruker Xtreme Imaging System within its contract research services division. This is the first such machine in the UK and will enable Epistem to expand both the range and throughput of its imaging services, particularly in the field of oncology. The Bruker Xtreme provides high sensitivity luminescence, fluorescence, radio-isotopic and radiographic (X-ray) imaging. Combined with Epistem's specialized pre-clinical knowledge this increases the range of assays the company can provide to its clients as well as their ability to identify new targets for cancer therapy.
"We are excited to have installed the UKs first machine. This new platform combines highly sensitive capabilities in a unified system, and provides us with a means to track tumour cells, visualise inflammation, and provide high throughput pharmacodynamic studies." said Dr. Catherine Booth, Co-Founder and Managing Director of the Contract Services Business. "Epistem's contract research service is committed to providing high quality, reliable and innovative pre-clinical models and services."
Bruker commented "The successful installation of the Xtreme system at Epistem marks our first UK site. The Xtreme is a highly sensitive imaging system with the added advantages of modularity and flexibility. It's unique design will provide major benefits to Epistem's pre-clinical drug development services."
Notes for editors
Epistem is a biotechnology and personalised medicine company commercialising its expertise in stem cells in the areas of epithelial (oncology, gastrointestinal and dermatological) and infectious diseases. Epistem develops innovative therapeutics, biomarkers and diagnostics (Genedrive®) alongside contract research services for drug development companies. The Group's core expertise is focused around the regulation of adult stem cells located in epithelial tissue including the gastrointestinal tract, skin, hair follicles, breast and prostate and utilizing novel, proprietary next generation molecular biology for use in personalised medicine. www.epistem.co.uk
Chief Executive Officer
+44 161 606 7258
The Internet of Things is clearly many things: data collection and analytics, wearables, Smart Grids and Smart Cities, the Industrial Internet, and more. Cool platforms like Arduino, Raspberry Pi, Intel's Galileo and Edison, and a diverse world of sensors are making the IoT a great toy box for developers in all these areas. In this Power Panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists discussed what things are the most important, which will have the most profound...
Dec. 1, 2015 06:30 AM EST Reads: 512
Dec. 1, 2015 06:00 AM EST Reads: 271
Dec. 1, 2015 05:00 AM EST Reads: 620
Dec. 1, 2015 05:00 AM EST Reads: 359
Dec. 1, 2015 04:45 AM EST Reads: 457
Dec. 1, 2015 04:15 AM EST
Dec. 1, 2015 03:30 AM EST Reads: 532
Dec. 1, 2015 03:00 AM EST Reads: 469
Dec. 1, 2015 03:00 AM EST Reads: 470
Dec. 1, 2015 03:00 AM EST Reads: 110
Dec. 1, 2015 01:15 AM EST Reads: 125
Dec. 1, 2015 01:00 AM EST Reads: 436
Nov. 30, 2015 10:00 PM EST Reads: 288
Nov. 30, 2015 03:45 PM EST Reads: 115
Nov. 30, 2015 03:15 PM EST Reads: 250